Page last updated: 2024-12-08

etamycin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

etamycin: antibiotic substance (macrolide lactone) produced by Streptomyces griseus & allied Streptomyces; active against gram-positive Mycobacterium tuberculosis & some fungi & other coccal infections; see also neoviridogriseins; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID91865074
MeSH IDM0046111

Synonyms (15)

Synonym
299-20-7
antibiotic f-1370a
viridogrisein i
brn 0078383
antibiotic k-179
neoviridogrisein iv
etamycin a
etamycin
unii-paf72p8t3g
paf72p8t3g ,
4-27-00-09723 (beilstein handbook reference)
glycine, n-((3-hydroxy-2-pyridinyl)carbonyl)-l-threonyl-d-leucyl-(4r)-4-hydroxy-d-prolyl-n-methylglycyl-n,4-dimethyl-l-isoleucyl-l-alanyl-n-methyl-2-phenyl-, (7->13)-lactone, (2s)-
etamycin [mi]
3-hydroxy-n-[(3r,6s,7r,10s,13s,16s,22r,24r)-24-hydroxy-7,11,13,17,20-pentamethyl-16-[(2s)-3-methylbutan-2-yl]-3-(2-methylpropyl)-2,5,9,12,15,18,21-heptaoxo-10-phenyl-8-oxa-1,4,11,14,17,20-hexazabicyclo[20.3.0]pentacosan-6-yl]pyridine-2-carboxamide
DTXSID001028203
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (16.67)18.7374
1990's5 (27.78)18.2507
2000's1 (5.56)29.6817
2010's8 (44.44)24.3611
2020's1 (5.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (5.56%)5.53%
Reviews1 (5.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]